{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:46:03Z","timestamp":1775605563794,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00259-023-06219-y","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:03:11Z","timestamp":1681189391000},"page":"2683-2691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma"],"prefix":"10.1007","volume":"50","author":[{"given":"Jiajin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beiwen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"6219_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41408-021-00560-x","volume":"11","author":"YN Shapiro","year":"2021","unstructured":"Shapiro YN, Peppercorn JM, Yee AJ, Branagan AR, Raje NS, Donnell EKO. Lifestyle considerations in multiple myeloma. Blood Cancer J. 2021;11:172. https:\/\/doi.org\/10.1038\/s41408-021-00560-x.","journal-title":"Blood Cancer J."},{"key":"6219_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4049\/jimmunol.121.2.409","volume":"121","author":"K Hammerton","year":"1978","unstructured":"Hammerton K, Cooper DA, Duckett M, Penny R. Biosynthesis of immunoglobulin in human immunoproliferative diseases. I. Kinetics of synthesis and secretion of immunoglobulin and protein by bone marrow cells in myeloma. J Immunol. 1978;121:409\u201317.","journal-title":"J Immunol."},{"key":"6219_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4161\/mabs.2.3.11755","volume":"2","author":"HK Khor","year":"2010","unstructured":"Khor HK, Jacoby ME, Squier TC, Chu GC, Chelius D. Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymes. mAbs. 2010;2:299\u2013308. https:\/\/doi.org\/10.4161\/mabs.2.3.11755.","journal-title":"mAbs."},{"key":"6219_CR4","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/s00259-019-04337-0","volume":"46","author":"D Kim","year":"2019","unstructured":"Kim D, Chun JH, Kim SH, Moon JH, Kang SG, Chang JH, et al. Re-evaluation of the diagnostic performance of (11)C-methionine PET\/CT according to the 2016 WHO classification of cerebral gliomas. Eur J Nucl Med Mol Imaging. 2019;46:1678\u201384. https:\/\/doi.org\/10.1007\/s00259-019-04337-0.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6219_CR5","doi-asserted-by":"publisher","unstructured":"Morales-Lozano MI, Viering O, Samnick S, Rodriguez-Otero P, Buck AK, Marcos-Jubilar M, et al. (18)F-FDG and (11)C-Methionine PET\/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers. Cancers. 2020:12. https:\/\/doi.org\/10.3390\/cancers12041042.","DOI":"10.3390\/cancers12041042"},{"key":"6219_CR6","doi-asserted-by":"publisher","first-page":"622501","DOI":"10.3389\/fonc.2020.622501","volume":"10","author":"F Matteucci","year":"2020","unstructured":"Matteucci F, Paganelli G, Martinelli G, Cerchione C. PET\/CT in Multiple Myeloma: Beyond FDG. Front Oncol. 2020;10:622501. https:\/\/doi.org\/10.3389\/fonc.2020.622501.","journal-title":"Front Oncol."},{"issue":"8","key":"6219_CR7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2967\/jnumed.121.262668","volume":"63","author":"G Wang","year":"2021","unstructured":"Wang G, Nardo L, Parikh M, Abdelhafez YG, Li E, Spencer BA, et al. Total-Body PET Multiparametric Imaging of Cancer Using a Voxel-wise Strategy of Compartmental Modeling. J Nucl Med. 2021;63(8):1274\u201381. https:\/\/doi.org\/10.2967\/jnumed.121.262668.","journal-title":"J Nucl Med."},{"issue":"4","key":"6219_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2967\/jnumed.120.261651","volume":"63","author":"Y Wu","year":"2021","unstructured":"Wu Y, Feng T, Zhao Y, Xu T, Fu F, Huang Z, et al. Whole-body Parametric Imaging of FDG PET using uEXPLORER with Reduced Scan Time. J Nucl Med. 2021;63(4):622\u20138. https:\/\/doi.org\/10.2967\/jnumed.120.261651.","journal-title":"J Nucl Med."},{"key":"6219_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.apradiso.2004.07.006","volume":"62","author":"M Mitterhauser","year":"2005","unstructured":"Mitterhauser M, Wadsak W, Krcal A, Schmaljohann J, Eidherr H, Schmid A, et al. New aspects on the preparation of [11C]Methionine--a simple and fast online approach without preparative HPLC. Appl Radiat Isot. 2005;62:441\u20135. https:\/\/doi.org\/10.1016\/j.apradiso.2004.07.006.","journal-title":"Appl Radiat Isot."},{"key":"6219_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2967\/jnumed.119.230565","volume":"61","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xie Z, Berg E, Judenhofer MS, Liu W, Xu T, et al. Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER. J Nucl Med. 2020;61:285\u201391. https:\/\/doi.org\/10.2967\/jnumed.119.230565.","journal-title":"J Nucl Med."},{"key":"6219_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.mnm.0000134329.30912.49","volume":"25","author":"G Lucignani","year":"2004","unstructured":"Lucignani G, Paganelli G, Bombardieri E. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun. 2004;25:651\u20136. https:\/\/doi.org\/10.1097\/01.mnm.0000134329.30912.49.","journal-title":"Nucl Med Commun."},{"key":"6219_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nucmedbio.2014.07.006","volume":"42","author":"J Bolcaen","year":"2015","unstructured":"Bolcaen J, Descamps B, Deblaere K, Boterberg T, De Vos PF, Kalala JP, et al. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study. Nucl Med Biol. 2015;42:38\u201345. https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.07.006.","journal-title":"Nucl Med Biol."},{"key":"6219_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008;3:6\u201312. https:\/\/doi.org\/10.1097\/JTO.0b013e31815e6d6b.","journal-title":"J Thorac Oncol."},{"key":"6219_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","volume":"31","author":"PE Kinahan","year":"2010","unstructured":"Kinahan PE, Fletcher JW. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31:496\u2013505. https:\/\/doi.org\/10.1053\/j.sult.2010.10.001.","journal-title":"Semin Ultrasound CT MR."},{"key":"6219_CR15","doi-asserted-by":"publisher","first-page":"9256858","DOI":"10.1155\/2017\/9256858","volume":"2017","author":"L Jodal","year":"2017","unstructured":"Jodal L, Jensen SB, Nielsen OL, Afzelius P, Borghammer P, Alstrup AKO, et al. Kinetic Modelling of Infection Tracers [(18)F]FDG, [(68)Ga]Ga-Citrate, [(11)C]Methionine, and [(11)C]Donepezil in a Porcine Osteomyelitis Model. Contrast Media Mol Imaging. 2017;2017:9256858. https:\/\/doi.org\/10.1155\/2017\/9256858.","journal-title":"Contrast Media Mol Imaging."},{"key":"6219_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2967\/jnumed.119.229740","volume":"61","author":"M Grkovski","year":"2020","unstructured":"Grkovski M, Goel R, Krebs S, Staton KD, Harding JJ, Mellinghoff IK, et al. Pharmacokinetic Assessment of (18)F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer. J Nucl Med. 2020;61:357\u201366. https:\/\/doi.org\/10.2967\/jnumed.119.229740.","journal-title":"J Nucl Med."},{"key":"6219_CR17","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1007\/s00259-022-05858-x","volume":"49","author":"I Polvoy","year":"2022","unstructured":"Polvoy I, Seo Y, Parker M, Stewart M, Siddiqua K, Manacsa HS, et al. Imaging joint infections using D-methyl-(11)C-methionine PET\/MRI: initial experience in humans. Eur J Nucl Med Mol Imaging. 2022;49:3761\u201371. https:\/\/doi.org\/10.1007\/s00259-022-05858-x.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6219_CR18","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/s41598-021-82217-0","volume":"11","author":"M Nakajo","year":"2021","unstructured":"Nakajo M, Ojima S, Kawakami H, Tani A, Hirayama A, Jinguji M, et al. Value of Patlak Ki images from (18)F-FDG-PET\/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis. Sci Rep. 2021;11:2729. https:\/\/doi.org\/10.1038\/s41598-021-82217-0.","journal-title":"Sci Rep."},{"key":"6219_CR19","first-page":"226","volume":"10","author":"M Lubberink","year":"2020","unstructured":"Lubberink M, Eriksson O. [(11)C]5-Hydroxy-tryptophan model for quantitative assessment of in vivo serotonin biosynthesis, retention and degradation in the endocrine pancreas. Am J Nucl Med Mol Imaging. 2020;10:226\u201334.","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"6219_CR20","doi-asserted-by":"publisher","first-page":"102504","DOI":"10.1118\/1.4820367","volume":"40","author":"P Kletting","year":"2013","unstructured":"Kletting P, Schimmel S, Kestler HA, Hanscheid H, Luster M, Fernandez M, et al. Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient. Med Phys. 2013;40:102504. https:\/\/doi.org\/10.1118\/1.4820367.","journal-title":"Med Phys."},{"key":"6219_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40658-021-00427-x","volume":"8","author":"D Hardiansyah","year":"2021","unstructured":"Hardiansyah D, Riana A, Kletting P, Zaid NRR, Eiber M, Pawiro SA, et al. A population-based method to determine the time-integrated activity in molecular radiotherapy. EJNMMI Phys. 2021;8:82. https:\/\/doi.org\/10.1186\/s40658-021-00427-x.","journal-title":"EJNMMI Phys."},{"issue":"Suppl 1","key":"6219_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0305-7372(06)80004-6","volume":"32","author":"E Terpos","year":"2006","unstructured":"Terpos E. Biochemical markers of bone metabolism in multiple myeloma. Cancer Treat Rev. 2006;32(Suppl 1):15\u20139. https:\/\/doi.org\/10.1016\/s0305-7372(06)80004-6.","journal-title":"Cancer Treat Rev."},{"key":"6219_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple Myeloma: Molecular Imaging with 11C-Methionine PET\/CT--Initial Experience. Radiology. 2007;242:498\u2013508. https:\/\/doi.org\/10.1148\/radiol.2422051980.","journal-title":"Radiology."},{"key":"6219_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","volume":"9","author":"MC Schimmelpennink","year":"2019","unstructured":"Schimmelpennink MC, Vorselaars ADM, Veltkamp M, Keijsers RGM. Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET\/CT: SUVmax versus total lung glycolysis. EJNMMI Res. 2019;9:54. https:\/\/doi.org\/10.1186\/s13550-019-0505-x.","journal-title":"EJNMMI Res."},{"key":"6219_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","volume":"128","author":"M Bolzoni","year":"2016","unstructured":"Bolzoni M, Chiu M, Accardi F, Vescovini R, Airoldi I, Storti P, et al. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target. Blood. 2016;128:667\u201379. https:\/\/doi.org\/10.1182\/blood-2016-01-690743.","journal-title":"Blood."},{"key":"6219_CR26","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.7150\/thno.20491","volume":"7","author":"C Lapa","year":"2017","unstructured":"Lapa C, Garcia-Velloso MJ, Luckerath K, Samnick S, Schreder M, Otero PR, et al. (11)C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions. Theranostics. 2017;7:2956\u201364. https:\/\/doi.org\/10.7150\/thno.20491.","journal-title":"Theranostics."},{"key":"6219_CR27","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1073\/pnas.93.5.1841","volume":"93","author":"H Hsu","year":"1996","unstructured":"Hsu H, Yu YM, Babich JW, Burke JF, Livni E, Tompkins RG, et al. Measurement of muscle protein synthesis by positron emission tomography with L-[methyl-11C]methionine. Proc Natl Acad Sci U S A. 1996;93:1841\u20136. https:\/\/doi.org\/10.1073\/pnas.93.5.1841.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"6219_CR28","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.1073\/pnas.95.22.12793","volume":"95","author":"AJ Fischman","year":"1998","unstructured":"Fischman AJ, Yu YM, Livni E, Babich JW, Young VR, Alpert NM, et al. Muscle protein synthesis by positron-emission tomography with L-[methyl-11C]methionine in adult humans. Proc Natl Acad Sci U S A. 1998;95:12793\u20138. https:\/\/doi.org\/10.1073\/pnas.95.22.12793.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"6219_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbapap.2009.10.004","volume":"1804","author":"MV Martinov","year":"2010","unstructured":"Martinov MV, Vitvitsky VM, Banerjee R, Ataullakhanov FI. The logic of the hepatic methionine metabolic cycle. Biochim Biophys Acta. 2010;1804:89\u201396. https:\/\/doi.org\/10.1016\/j.bbapap.2009.10.004.","journal-title":"Biochim Biophys Acta."},{"key":"6219_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13550-020-00700-7","volume":"10","author":"L Mu","year":"2020","unstructured":"Mu L, Kramer SD, Warnock GI, Haider A, Bengs S, Cartolano G, et al. [(11)C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [(18)F]LMI1195 uptake is NET-independent. EJNMMI Res. 2020;10:114. https:\/\/doi.org\/10.1186\/s13550-020-00700-7.","journal-title":"EJNMMI Res."},{"key":"6219_CR31","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2967\/jnumed.115.157586","volume":"56","author":"FE Froklage","year":"2015","unstructured":"Froklage FE, Boellaard R, Bakker E, Hendrikse NH, Reijneveld JC, Schuit RC, et al. Quantification of 11C-Laniquidar Kinetics in the Brain. J Nucl Med. 2015;56:1730\u20135. https:\/\/doi.org\/10.2967\/jnumed.115.157586.","journal-title":"J Nucl Med."},{"key":"6219_CR32","doi-asserted-by":"publisher","unstructured":"El Arfani C, De Veirman K, Maes K, De Bruyne E, Menu E. Metabolic Features of Multiple Myeloma. Int J Mol Sci. 2018:19. https:\/\/doi.org\/10.3390\/ijms19041200.","DOI":"10.3390\/ijms19041200"},{"key":"6219_CR33","doi-asserted-by":"publisher","unstructured":"Stong N, Ortiz Estevez M, Towfic F, Samur MK, Agarwal A, Corre J, et al. Location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of high-risk NDMM patients. Blood. 2022; https:\/\/doi.org\/10.1182\/blood.2022016212.","DOI":"10.1182\/blood.2022016212"},{"key":"6219_CR34","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18:e206\u2013e17. https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4.","journal-title":"Lancet Oncol."},{"key":"6219_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006.","journal-title":"Cell Metab."},{"key":"6219_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jcp.2007.049585","volume":"61","author":"J Yeung","year":"2008","unstructured":"Yeung J, Chang H. Genomic aberrations and immunohistochemical markers as prognostic indicators in multiple myeloma. J Clin Pathol. 2008;61:832\u20136. https:\/\/doi.org\/10.1136\/jcp.2007.049585.","journal-title":"J Clin Pathol."},{"key":"6219_CR37","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/modpathol.2010.174","volume":"23","author":"N Dreux","year":"2010","unstructured":"Dreux N, Marty M, Chibon F, Velasco V, Hostein I, Ranchere-Vince D, et al. Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol. 2010;23:1657\u201366. https:\/\/doi.org\/10.1038\/modpathol.2010.174.","journal-title":"Mod Pathol."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06219-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06219-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06219-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:03:39Z","timestamp":1688375019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06219-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6219"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06219-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were approved by the Institutional Review Board of Shanghai Jiao Tong University-affiliated Ren Ji Hospital and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not describe any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}